SAT035 Oligonucleotide IMT504 Markedly Improves Metabolic Sindrome And Type 2 Diabetes In High-Fat Diet Fed Mice

Disclosure: L. Domé: None. J.M. Riaño Gomez: None. M.M. Bonaventura: None. M.O. Fernandez: None. A.D. Montaner: None. V.A. Lux-Lantos: None. M.S. Bianchi: None. We have shown that the immunomodulatory oligonucleotide IMT504 (IMT) improves glucose homeostasis in several animal models of type 1 diabet...

Descripción completa

Detalles Bibliográficos
Autores principales: Domé, Laila, Riaño Gomez, Juan Manuel, Marta Bonaventura, María, Olga Fernandez, Marina, Daniel Montaner, Alejandro, Adela Lux-Lantos, Victoria, Silvia Bianchi, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Diabetes And Glucose Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555959/
http://dx.doi.org/10.1210/jendso/bvad114.903

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555959/
http://dx.doi.org/10.1210/jendso/bvad114.903

Ejemplares similares